Physician profile
Lyda Rodriguez
NPI 1629079322
$1,027.57
in general payments reported to CMS, 2019-2025
17 companies · $143 in 2025
The $143 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $167 · 2021: $146 · 2022: $128 · 2023: $112 · 2024: $140 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $161.31 | 2021-2023 | Azstarys, Azstarys |
| Tris Pharma INC | $160.83 | 2019-2025 | Quillivant |
| Glaxosmithkline, LLC. | $107.74 | 2020-2025 | Bexsero, Rotarix |
| Takeda Pharmaceuticals U.S.A., INC. | $102.43 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $71.26 | 2024-2025 | |
| Seqirus USA INC | $65.90 | 2023-2024 | Flucelvax, Flucelvax Quadrivalent |
| Cranial Technologies, INC | $53.14 | 2019-2025 | Doc Band |
| Adlon Therapeutics L.P. | $48.22 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $47.73 | 2019-2023 | Vaxelis, Vaxneuvance, M-M-R II |
| Sanofi Pasteur INC. | $47.72 | 2019-2020 | |
| Neos Therapeutics, LP | $43.72 | 2019-2020 | |
| Pfizer INC. | $27.57 | 2019 | |
| Biomarin Pharmaceutical INC. | $20.74 | 2025 | Voxzogo 1.2mg |
| Verrica Pharmaceuticals INC. | $20.52 | 2024 | Ycanth |
| Teva Pharmaceuticals USA, INC. | $18.70 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $15.90 | 2019 | |
| Alk-Abello, INC | $14.14 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lyda Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.